Among them, CCR1, CCR2, CCR3, and CCR5 promote the recruitment of TAMs in the TME, and CCR4 mainly mediates the recruitment of Tregs, indicating that CC chemokines can be used as potential anti‐tumor pharmacological targets.82, 175. The gene discussed is CCR4; the disease is neoplasm.